ROBYN VANDERFORD: Open Payments
NPI 1437334216 · COVINGTON, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$360 in 18 payments from 10 companies in 2025. Trend: 2023 $114 · 2024 $568 · 2025 $360
Food & beverage: $360
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 4 | $83 |
| ABBVIE INC. | 4 | $73 |
| Novo Nordisk Inc | 2 | $47 |
| GlaxoSmithKline, LLC. | 2 | $34 |
| Averitas Pharma Inc. | 1 | $30 |
| Pacira Pharmaceuticals Incorporated | 1 | $23 |
| AstraZeneca Pharmaceuticals LP | 1 | $20 |
| Ascensia Diabetes Care Us Inc. | 1 | $18 |
| PFIZER INC. | 1 | $16 |
| Exact Sciences Corporation | 1 | $16 |
Products named: QULIPTA, JARDIANCE, TRELEGY ELLIPTA, MOUNJARO, QUTENZA, Rybelsus, Iovera, AIRSUPRA.
Industry payments across TN — which companies pay providers there.
